Framework Agreement for the selection of seasonal influenza vaccine suppliers for certain contracting bodies of the AGE, the National Institute of Health Management (INGESA) and the cities of Ceuta and Melilla and several Autonomous Communities.

Inactivated vaccines produced from viruses grown in embryonated eggs, from fractionated viruses, or from surface antigens (H and N), or the like containing 3 strains of influenza virus.

Inactivated vaccines produced from viruses grown in embryonated eggs, from fractionated viruses, or from surface antigens (H and N), or the like containing 4 strains of influenza virus.

Inactivated vaccines produced from viruses grown in embryonated eggs, 15 micrograms of hemagglutinin, with adjuvant or the like.

Inactivated vaccines produced from viruses grown in cell culture, from fractionated viruses, or from surface antigens (H and N) or the like.